Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharma Mar, a biopharmaceutical company headquartered in Spain, specializes in the discovery, development, and commercialization of cancer drugs. Through innovative research, Pharma Mar focuses on novel therapies for treating various tumor types. The company strives to improve the quality of life for cancer patients globally with its groundbreaking medicines.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharma Mar is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharma Mar last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at -0.06 EUR.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.